IL141402A0 - Preventives/remedies for multiple organ failure - Google Patents

Preventives/remedies for multiple organ failure

Info

Publication number
IL141402A0
IL141402A0 IL14140299A IL14140299A IL141402A0 IL 141402 A0 IL141402 A0 IL 141402A0 IL 14140299 A IL14140299 A IL 14140299A IL 14140299 A IL14140299 A IL 14140299A IL 141402 A0 IL141402 A0 IL 141402A0
Authority
IL
Israel
Prior art keywords
preventives
remedies
organ failure
multiple organ
failure
Prior art date
Application number
IL14140299A
Other languages
English (en)
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of IL141402A0 publication Critical patent/IL141402A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL14140299A 1998-09-03 1999-09-03 Preventives/remedies for multiple organ failure IL141402A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10249492A JP2000080046A (ja) 1998-09-03 1998-09-03 多臓器障害の予防・治療剤
PCT/JP1999/004783 WO2000013707A1 (fr) 1998-09-03 1999-09-03 Medicaments preventifs/et remedes contre la defaillance de plusieurs organes

Publications (1)

Publication Number Publication Date
IL141402A0 true IL141402A0 (en) 2002-03-10

Family

ID=17193786

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14140299A IL141402A0 (en) 1998-09-03 1999-09-03 Preventives/remedies for multiple organ failure

Country Status (12)

Country Link
US (1) US6596754B1 (no)
EP (1) EP1110556A4 (no)
JP (1) JP2000080046A (no)
KR (1) KR20010099628A (no)
CN (1) CN1315873A (no)
AU (1) AU5448699A (no)
CA (1) CA2342796A1 (no)
ID (1) ID28693A (no)
IL (1) IL141402A0 (no)
NO (1) NO20011096L (no)
TW (1) TW533074B (no)
WO (1) WO2000013707A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579325B2 (en) 2001-03-21 2009-08-25 Eisai R & D Management Co., Ltd. Drugs containing reduced of vitamin B2
AU2003284596A1 (en) * 2002-11-22 2004-06-18 Takeda Pharmaceutical Company Limited Imidazole derivative, process for producing the same, and use
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
CA2610157A1 (en) * 2005-06-09 2006-12-21 Bristol-Myers Squibb Company Methods of identifying and treating individuals exhibiting mutant kit protein
US10646313B2 (en) 2016-10-12 2020-05-12 Solmetex, L.L.C. Dental amalgam separation and recycling system
AU2018253392B2 (en) 2017-04-14 2023-11-02 Capsugel Belgium Nv Process for making pullulan
JP2020516653A (ja) 2017-04-14 2020-06-11 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップCapsugel Belgium NV プルランカプセル
WO2019241213A1 (en) * 2018-06-11 2019-12-19 The Regents Of The University Of Colorado, A Body Corporate 2-naphthimidamides, analogues thereof, and methods of treatment using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466668A (en) * 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
IL101062A0 (en) * 1991-02-28 1992-11-15 Erba Carlo Spa Anti-thrombin polypeptides and their preparation
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JP3388803B2 (ja) * 1993-05-20 2003-03-24 第一製薬株式会社 光学活性7−アミジノナフタレン誘導体の製造法

Also Published As

Publication number Publication date
CN1315873A (zh) 2001-10-03
CA2342796A1 (en) 2000-03-16
EP1110556A1 (en) 2001-06-27
JP2000080046A (ja) 2000-03-21
AU5448699A (en) 2000-03-27
TW533074B (en) 2003-05-21
KR20010099628A (ko) 2001-11-09
NO20011096D0 (no) 2001-03-02
US6596754B1 (en) 2003-07-22
ID28693A (id) 2001-06-28
NO20011096L (no) 2001-03-02
WO2000013707A1 (fr) 2000-03-16
EP1110556A4 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
DE69922944D1 (en) Lichtquelle für photodynamische therapie
GB9825651D0 (en) Actuator
AU3898999A (en) Aloe pectins
AU138616S (en) Humidifier
AU5647099A (en) Remedal or preventive agent for congestive heart failure
EP1053749A4 (en) PREVENTION AND MEDICINE FOR NEURODEGENERATIVE DISEASES
HUP9901642A3 (en) Remedies or preventives for aids
IL141402A0 (en) Preventives/remedies for multiple organ failure
AU3987800A (en) Preventives/remedies for angiostenosis
GB2344402B (en) Actuator
IL142557A0 (en) Remedies for bone metabolic errors
GB9810529D0 (en) Intumescent composition
EP1055429A4 (en) NEW PREVENTION MEDICINE / MEDICINE FOR IMMUNOPATHIES
EP1297839A4 (en) THERAPEUTIC AND PROPHYLACTIC AGENTS FOR CARDIAC INSUFFICIENCY
IL140674A0 (en) Remedies or preventives for intractable epilepsy
EP1157697A4 (en) REMEDIES FOR HYPERAMMONIA
EP1057491A4 (en) PREVENTIVE MEANS / REMEDIES AGAINST SKIN AGING
GB2334675B (en) Improved intumescent ventilator
HK1021261A1 (en) Joint box.
GB9823389D0 (en) Humidifiers
HK1041643A1 (en) Preventives for hepatopathy.
AU6006099A (en) Preventives or remedies for cachexia
EP1061636A4 (en) ACTUATOR
EP0983763A4 (en) MEDICINES AGAINST RECONSTRICTION
EP0976400A4 (en) PREVENTIVE MEASURES AND REMEDY FOR KIDNEY DISEASE